Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2013

Primary Completion Date

November 16, 2016

Study Completion Date

November 16, 2016

Conditions

Giant Cell GlioblastomaGlioblastomaGliosarcoma

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

Given ID

DRUG

Temozolomide

Given PO

Trial Locations (1)

Mayo Clinic, Rochester